Dr. Aimee (Amy) Nefcy

speaker

802 appearances 1 recordings 1 series first heard Dec 2025 last heard 20 Dec

Dr. Aimee (Amy) Nefcy’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Dec 2025 with 1.

Appearances

newest first · ▶ plays the moment

The Neurotransmitters: Clinical Neurology Education · Beyond Tired: Understanding ME/CFS · 20 Dec 2025 podcast

Because I've only seen, you know, minor improvements since the beginning of the year, which is when I started the trazodone.

And one of the things that came up on that search was aripiprazole, which I found very interesting because one of the treatments that is promoted by Stanford for ME-CFS is what they call low-dose aripiprazole.

And they'll do like one milligram or even half a milligram a day

And somehow it helps with fatigue for people who have CFS in a minority of patients.

But with ME-CFS, if you're talking about 30 percent improvement, people will take that.

If it means not being housebound, you know.

So that's next on my list of things to try.

I've also tried low-dose naltrexone, which is something that I encountered early on in my research, is used for fibromyalgia and other chronic pain syndromes.

And as a toxicologist, naltrexone makes sense to me because of its effects on the new opioid receptors.

But it hasn't worked for me.

It hasn't done anything.

And I don't really have a lot of pain.

So maybe that makes sense.

Right.

That seems crazy to me, you know?

So early on when I started considering the diagnosis of ME, it got into a lot of support groups that are for patients and stuff like that.

And that was instrumental in cementing my diagnosis in my mind because I had the things that they had.

you know, that they discussed in group.

But they come up with a lot of out there things sometimes.

But most of the time, it's pretty benign.

Showing 441–460 of 802 · page 23 of 41